203
Views
21
CrossRef citations to date
0
Altmetric
Original Articles

Chronic Recurrent Vogt–Koyanagi–Harada Disease and Development of ‘Sunset Glow Fundus’ Predict Worse Retinal Sensitivity

, MD, PhD, , MD, , MD, , MD, , COT, , PhD & , MD show all
Pages 475-485 | Received 27 Jul 2015, Accepted 05 Jan 2016, Published online: 22 Mar 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Abdulrahman F. AlBloushi, Saad H. AlEnezi, Adi Mohammed Al Owaifeer, Omar S. Al-Hadlaq, Priscilla W. Gikandi & Ahmed M. Abu El-Asrar. (2022) Long-term Outcomes of Uveitis Associated with Vogt-Koyanagi-Harada Disease in the Pediatric Age Group. Ocular Immunology and Inflammation 30:7-8, pages 1669-1677.
Read now
Shunsaku Nakai, Masaru Takeuchi, Yoshihiko Usui, Kenichi Namba, Kayo Suzuki, Yosuke Harada, Sentaro Kusuhara, Toshikatsu Kaburaki, Rie Tanaka, Masaki Takeuchi, Nobuhisa Mizuki, Kei Nakai, Hiroshi Goto & Carl P. Herbort$suffix/text()$suffix/text(). (2022) Efficacy and Safety of Adalimumab for Exacerbation or Relapse of Ocular Inflammation in Patients with Vogt-Koyanagi-Harada Disease: A Multicenter Study. Ocular Immunology and Inflammation 0:0, pages 1-9.
Read now
Ahmed M. Abu El-Asrar, Abdulsalam Dheyab, Dina Khatib, Sofie Struyf, Jo Van Damme & Ghislain Opdenakker. (2022) Efficacy of B Cell Depletion Therapy with Rituximab in Refractory Chronic Recurrent Uveitis Associated with Vogt-Koyanagi-Harada Disease. Ocular Immunology and Inflammation 30:3, pages 750-757.
Read now
Atsunobu Takeda, Eiichi Hasegawa, Shoji Notomi, Keijiro Ishikawa, Mitsuru Arima, Yusuke Murakami, Shintaro Nakao, Toshio Hisatomi & Koh-Hei Sonoda. (2021) Surgical Outcomes of Contrast Sensitivity and Visual Acuity in Uveitis-Associated Cataract. Clinical Ophthalmology 15, pages 2665-2673.
Read now
Abdulrahman F. AlBloushi, Abdullah M. Alfawaz, Abdulrahman AlZaid, Abrar K. Alsalamah, Priscilla W. Gikandi & Ahmed M. Abu El-Asrar. (2021) Incidence, Risk Factors and Surgical Outcomes of Cataract among Patients with Vogt-Koyanagi-Harada Disease. Ocular Immunology and Inflammation 29:1, pages 128-136.
Read now

Articles from other publishers (16)

Ahmed M. Abu El‐Asrar, Faisal A. Al Rashed, Abdulrahman F. AlBloushi, Mohannad F. Tobaigy, Priscilla W. Gikandi, Carl P. HerbortJr.Jr. & Ghislain Opdenakker. (2022) Therapeutic window of opportunity in the acute uveitic phase of Vogt–Koyanagi–Harada disease: Prevention of late autoimmune complications by early intervention . Acta Ophthalmologica 101:2.
Crossref
Cristhian A. Urzua, Carl P. HerbortJrJr, Masaru Takeuchi, Ariel Schlaen, Luz E. Concha-del-Rio, Yoshihiko Usui, Loreto Cuitino & Ioannis Papasavvas. (2022) Vogt-Koyanagi-Harada disease: the step-by-step approach to a better understanding of clinicopathology, immunopathology, diagnosis, and management: a brief review. Journal of Ophthalmic Inflammation and Infection 12:1.
Crossref
Hyo Song Park, Hyun Young Park, Christopher Seungkyu Lee, Sung Chul LeeJi Hwan Lee. (2022) EFFICACY OF COMBINED SYSTEMIC CORTICOSTEROID AND EARLY IMMUNOMODULATORY THERAPY WITHIN THREE MONTHS OF ONSET IN VOGT–KOYANAGI–HARADA DISEASE. Retina 42:12, pages 2361-2367.
Crossref
Kailei Guo, Baiyi Li, Fuhua Yang, Mi Zhang, Guixia Zhao & Xiaomin Zhang. (2022) Different MicroRNA profiles in Peripheral Blood mononuclear cells from patients with initial-onset and recurrent vogt–Koyanagi–Harada Disease. Molecular Biology Reports 49:12, pages 11421-11431.
Crossref
Massimo Accorinti, Maria Carmela Saturno, Ludovico Iannetti, Priscilla Manni, Davide Mastromarino & Maria Pia Pirraglia. (2022) Treatment and Prognosis of Vogt–Koyanagi–Harada Disease: Real-Life Experience in Long-Term Follow-Up. Journal of Clinical Medicine 11:13, pages 3632.
Crossref
Masahiro Miura, Shuichi Makita, Yoshiaki Yasuno, Shinnosuke Azuma, Toshihiro Mino, Tatsuo Yamaguchi, Takuya Iwasaki, Rei Nemoto, Hiroyuki Shimizu & Hiroshi Goto. (2022) Objective evaluation of choroidal melanin loss in patients with Vogt–Koyanagi–Harada disease using polarization-sensitive optical coherence tomography. Scientific Reports 12:1.
Crossref
Carl P. HerbortJrJr, Ilknur Tugal-Tutkun, Ahmed Abu-El-Asrar, Amod Gupta, Masaru Takeuchi, Christine Fardeau, Alireza Hedayatfar, Cristhian Urzua & Ioannis Papasavvas. (2021) Precise, simplified diagnostic criteria and optimised management of initial-onset Vogt–Koyanagi–Harada disease: an updated review. Eye 36:1, pages 29-43.
Crossref
Fernanda Maria Silveira Souto, Ruy Felippe Brito Gonçalves Missaka, Marcelo Mendes Lavezzo, Viviane Mayumi Sakata, Maria Kiyoko Oyamada, Carlos Eduardo Hirata & Joyce Hisae Yamamoto. (2020) Associations between functional and structural measurements in non‐acute Vogt–Koyanagi–Harada disease. Acta Ophthalmologica 99:5.
Crossref
Cristhian A. Urzua, Carl HerbortJrJr, Rodrigo A. Valenzuela, Ahmed M. Abu El-Asrar, Lourdes Arellanes-Garcia, Ariel Schlaen, Joyce Yamamoto & Carlos Pavesio. (2020) Initial-onset acute and chronic recurrent stages are two distinctive courses of Vogt-Koyanagi-Harada disease. Journal of Ophthalmic Inflammation and Infection 10:1.
Crossref
Carl P. HerbortJr.Jr., Ilknur Tugal-Tutkun, Moncef Khairallah, Ahmed M. Abu el Asrar, Carlos E. Pavésio & Masoud Soheilian. (2020) Vogt–Koyanagi–Harada disease: recurrence rates after initial-onset disease differ according to treatment modality and geographic area. International Ophthalmology 40:9, pages 2423-2433.
Crossref
Irmak Karaca, Suzan Güven Yılmaz, Filiz Afrashi & Serhad Nalçacı. (2020) Assessment of macular capillary perfusion in patients with inactive Vogt-Koyanagi-Harada disease: an optical coherence tomography angiography study. Graefe's Archive for Clinical and Experimental Ophthalmology 258:6, pages 1181-1190.
Crossref
Toshihiko Murata, Nanae Sako, Kei Takayama, Kozo Harimoto, Koji Kanda, Carl P. Herbort & Masaru Takeuchi. (2019) Identification of Underlying Inflammation in Vogt–Koyanagi–Harada Disease with Sunset Glow Fundus by Multiple Analyses. Journal of Ophthalmology 2019, pages 1-7.
Crossref
Carl P. HerbortJr.Jr., Ahmed M. Abu El Asrar, Masuru Takeuchi, Carlos E. Pavésio, Cristobal Couto, Alireza Hedayatfar, Kazuichi Maruyama, Xi Rao, Sukhum Silpa-archa & Thanapong Somkijrungroj. (2018) Catching the therapeutic window of opportunity in early initial-onset Vogt–Koyanagi–Harada uveitis can cure the disease. International Ophthalmology 39:6, pages 1419-1425.
Crossref
Cristhian A. Urzua. 2019. Advances in the Diagnosis and Management of Uveitis. Advances in the Diagnosis and Management of Uveitis.
Alireza Hedayatfar, Sana Khochtali, Moncef Khairallah, Masaru Takeuchi, Ahmed Abu El Asrar & Carl P. HerbortJr.Jr.. (2019) “Revised diagnostic criteria” for Vogt-Koyanagi-Harada disease fail to improve disease management. Journal of Current Ophthalmology 31:1, pages 1-7.
Crossref
Carl P. Herbort Jr, Ahmed M. Abu El Asrar, Joyce H. Yamamoto, Carlos E. Pavésio, Vishali Gupta, Moncef Khairallah, Ilknur Tugal-Tutkun, Masoud Soheilian, Masuru Takeuchi & Marina Papadia. (2016) Reappraisal of the management of Vogt–Koyanagi–Harada disease: sunset glow fundus is no more a fatality. International Ophthalmology 37:6, pages 1383-1395.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.